HIGHLIGHTS
- who: Michal Tomcik from the InstitutCharles University have published the research: Frontiers of Targeted Therapy and Predictors of Treatment Response in Systemic Sclerosis, in the Journal: Biomedicines 2022, 10, 3053. of 14/Nov/2022
SUMMARY
Copyright: Systemic sclerosis (scleroderma, SSc) is one of the most challenging rheumatic diseases, characterized by vasculopathy, dysregulation of the immune_response, and progressive tissue fibrosis affecting the skin, lungs, heart, digestive tract, and kidneys. To date, it is considered incurable and carries the highest cause-specific mortality of all connective tissue diseases. This is especially true in the later . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.